Scientific Writers Series
Professional Development Webinars

The Centers for Disease Control and Prevention, in collaboration with TEPHINET and the World Hypertension League (WHL), have hosted several professional development series. Please see series information and links to recordings below.
Past Sessions of 2-part series:
Please see posted recordings and Q&A from this FETP NCD professional development series on Critiquing a Published Article presented by Professors Daniel T. Lackland, Michael A. Weber, and Paul K. Whelton of the World Hypertension League.
Part 1: Manuscript Peer Review Process October 10, 2024
Session Description: The session describes the importance and key components of the manuscript peer review process. You will also learn about the steps involved in the peer review process after you submit your manuscript and before it can be published.
Link to the recording 2-Part Series-Critiquing a Published Article: Part I-Manuscript Review Process
Part 2: Becoming a Peer Reviewer for Scientific Writing & Communication October 31, 2024
Session Description: This session introduces you to the approach and process of being a good peer reviewer. You will also learn about the typical roles and responsibilities of a reviewer, an editorial board member, a deputy editor, and an editor-in-chief, as well as their expectations.
Link to the recording 2-Part Series-Critiquing a Published Article: Part II-Becoming a Peer Reviewer
Past Sessions of 3-part Series
Please see posted recordings and Q&As from this 3-part series of virtual monthly professional development webinars, on Interpretation of Study Findings, presented by Professors Daniel T. Lackland, Michael A. Weber, and Paul K. Whelton of World Hypertension League. The webinar series topics included epidemiologic risk estimates, sensitivity, specificity predictive value, and more.
Part 1: Epidemiologic Measures and Risk Estimates July 18, 2024
Session Description: This session will describe the interpretation of different types of epidemiologic measures and teach you about the application of risk measures.
Link to the recording: 3-Part Interpretation of Study Findings Series: Part I: Epidemiologic Measures & Risk Estimates
Part 2: Sensitivity and Specificity August 15, 2024
Session Description: This session will introduce the basic statistical concepts for diagnostic testing, including the impact of pretest probability on clinical decision-making. You will also learn about identifying the elements of a high-value screening test and approaches to apply statistical tools to make high-value treatment decisions.
Link to the recording: 3-Part Interpretation of Study Findings Series: Part II: Sensitivity and Specificity
Part 3: Predictive Value and Diagnosis September 12, 2024
Session Description: This session will describe the accuracy of diagnosis tests and prediction tools, focusing on the value and interpretations of assessment metrics. It will also cover the application of predictive values in epidemiology and evidence-based medicine.
Past Sessions of 6-part FETP NCD Professional Development Series on Research Methodology:
Please see posted recordings and Q&As from this 6-part FETP NCD professional development series on Research Methodology that was held from January 18 through June 20, 2024, below. The series was taught by Professors Daniel T. Lackland, Michael A. Weber, and Paul K. Whelton of the World Hypertension League.
Part 1: Types of Studies and Risk Estimates - January 18, 2024
Link to the recording: 6-Part Research Methodology Series: Part 1- Types of Studies and Risk Estimates
Part 2: Bias in Epidemiological Studies - February 15, 2024
Session Description: This session will introduce the concept of bias and explain how to assess it. You will also learn about the concepts and assessment of random error.
Link to the recording: 6-Part Research Methodology Series: Part II - Bias in Epidemiological Studies
Part 3: Confounding - March 14, 2024
Session Description: This session will describe confounding and its effects on study results. It will also cover the strategies to reduce confounding.
Link to the recording: 6-Part Research Methodology Series: Part III - Confounding
Part 4: Epidemiology Abnormality, Risks, and Assessment - April 18, 2024
Session Description: This session will go over the ways of defining abnormal and risks, including the metrics and quantification of abnormal and risks.
Link to the recording: 6-Part Research Methodology Series: Part IV - Epidemiology Abnormality, Risks, and Assessments
Part 5: ROC Curves - May 16, 2024
Session Description: This session will introduce hypothesis testing with the ROC curve approach. It will also go over how to describe the use of the ROC curve methodology and introduce the Area under the ROC curve (AUC) methodology.
Link to the recording: 6-Part Research Methodology Series: Part V - ROC Curves
Part 6: Tools for Assessing Research Study Evidence – Quality of the Studies - June 20, 2024
Session Description: This session will describe the various methods for assessing the quality of different studies. It will also identify resources and instruments for assessing study results.
Link to the recording: 6-Part Research Methodology Series: Part VI- Tools for Assessing Research Study Evidence-Quality of the Studies

